Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Published 31/07/2023, 13:31
© Reuters.  Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Benzinga - Gainers

  • China Natural Resources, Inc. (NASDAQ: CHNR) shares surged 63.5% to $3.22 in pre-market trading after the company agreed to sell all outstanding shares of Precise Space-Time Technology Limited to Feishang Group Limited, together with PSTT's outstanding payable owed to the Company, for consideration of around RMB95,761,119 in cash.
  • FOXO Technologies Inc. (NYSE: FOXO) rose 45.3% to $0.1941 in pre-market trading.
  • Aurora Acquisition Corp. (NASDAQ: AURC) gained 29.6% to $57.08 in pre-market trading after jumping 113% on Friday
  • Nano Labs Ltd (NASDAQ: NA) shares gained 25% to $1.80 in pre-market trading after the company reported receipt of interest-free loans from shareholders.
  • Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares rose 18% to $0.1533 in pre-market trading.
  • Inpixon (NASDAQ: INPX) shares gained 16.6% to $0.2814 in pre-market trading after jumping 19% on Friday.
  • Barnes & Noble Education, Inc. (NYSE: BNED) shares climbed 16% to $1.45 in pre-market trading after the company entered into an agreement with key financial stakeholders and strategic partners to strengthen financial position and support growth initiatives.
  • Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 14.5% to $0.4479 in pre-market trading after gaining 5% on Friday.
  • Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) gained 13.9% to $36.47 in pre-market trading after the company issued an update on review of rare safety events with Syfovre for geographic atrophy.
  • Eos Energy Enterprises, Inc. (NASDAQ: EOSE) rose 11.5% to $2.52 in pre-market trading. Eos Energy Enterprises said it expects to record revenue of $0.2 million for the quarter ended June 30, 2023.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) fell 22.4% to $0.0737 in pre-market trading after the company announced NYSE American has commenced delisting proceedings and the company intends to appeal.
  • Unique Fabricating, Inc. (NYSE: UFAB) fell 17.6% to $0.2850 in pre-market trading after gaining 60% on Friday.
  • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) fell 16.3% to $0.2850 in pre-market trading. Sonnet BioTherapeutics, last month, announced a $2.25 million registered direct offering of 5 million at $0.45/share.
  • Troika Media Group, Inc. (NASDAQ: TRKA) shares fell 9.7% to $2.33 in pre-market trading after gaining over 7% on Friday.
  • Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) fell 9% to $1.02 in pre-market trading after the company received FDA Complete Response Letter for Lymphir (Denileukin Diftitox) for relapsed/refractory cutaneous T-cell lymphoma.
  • Satixfy Communications Ltd. (NASDAQ: SATX) shares fell 9.6% to $0.2985 in pre-market trading. SatixFy Communications recently named Mr. Nir Barkan as Acting Chief Executive Officer.
  • BioNexus Gene Lab Corp. (NASDAQ: BGLC) fell 8.7% to $2.74 in pre-market after jumping over 40% on Friday.
  • Akari Therapeutics, Plc (NASDAQ: AKTX) fell 8.2% to $0.2001 in pre-market trading. Akari Therapeutics was recently granted Nomacopan Orphan Drug Designation from the European Commission for treatment in hematopoietic stem cell transplantation.
  • Greenbrook TMS Inc. (NASDAQ: GBNH) shares fell 6.8% to $0.4685 in pre-market trading.
  • Femasys Inc. (NASDAQ: FEMY) fell 6.8% to $0.6061 in pre-market trading after dipping over 22% on Friday.

Now Read This: Market Volatility Falls Following June PCE Data; S&P 500 Settles Higher

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.